Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $64.5 million.

  • Tandem Diabetes Care's Accumulated Expenses rose 977.04% to $64.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.5 million, marking a year-over-year increase of 977.04%. This contributed to the annual value of $64.1 million for FY2024, which is 4765.83% up from last year.
  • As of Q3 2025, Tandem Diabetes Care's Accumulated Expenses stood at $64.5 million, which was up 977.04% from $51.7 million recorded in Q2 2025.
  • Over the past 5 years, Tandem Diabetes Care's Accumulated Expenses peaked at $64.5 million during Q3 2025, and registered a low of $32.7 million during Q1 2021.
  • Its 5-year average for Accumulated Expenses is $45.5 million, with a median of $43.4 million in 2023.
  • As far as peak fluctuations go, Tandem Diabetes Care's Accumulated Expenses surged by 5468.45% in 2021, and later crashed by 2497.09% in 2022.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Accumulated Expenses stood at $51.6 million in 2021, then dropped by 24.97% to $38.7 million in 2022, then rose by 12.27% to $43.4 million in 2023, then skyrocketed by 47.66% to $64.1 million in 2024, then increased by 0.51% to $64.5 million in 2025.
  • Its Accumulated Expenses was $64.5 million in Q3 2025, compared to $51.7 million in Q2 2025 and $50.4 million in Q1 2025.